{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:27:15Z","timestamp":1793827635099,"version":"4.6.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"48","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,21]]},"DOI":"10.1093\/eurheartj\/ehx585","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T15:12:16Z","timestamp":1506438736000},"page":"3560-3566","source":"Crossref","is-referenced-by-count":236,"title":["Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study"],"prefix":"10.1093","volume":"38","author":[{"given":"Mee Kyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Moon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Sang","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,21]]},"reference":[{"key":"key\n\t\t\t\t20171221045504_ehx585-B1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2016.06.054","article-title":"Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B2","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1532-5415.2006.00940.x","article-title":"Association between reduced heart rate variability and cognitive impairment in older disabled women in the community: women\u2019s health and aging study I","volume":"54","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/HYPERTENSIONAHA.110.162255","article-title":"The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B4","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.94.11.2850","article-title":"Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study","volume":"94","year":"1996","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B5","first-page":"i4098.","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","year":"2016","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B6","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2015.02.017","article-title":"Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial","volume":"65","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2015.10.110","article-title":"Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: a 5-year follow-up study","volume":"244","year":"2016","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.115.020627","article-title":"Higher visit-to-visit low-density lipoprotein cholesterol variability is associated with lower cognitive performance, lower cerebral blood flow, and greater white matter hyperintensity load in older subjects","volume":"134","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B9","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B10","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B11","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.111.088591","article-title":"Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the treating to new targets (TNT) study","volume":"125","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","article-title":"Data analytic process of a nationwide population-based study using National Health Information Database established by National Health Insurance Service","volume":"40","year":"2016","journal-title":"Diabetes Metab J"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B13","doi-asserted-by":"crossref","first-page":"30329.","DOI":"10.1038\/srep30329","article-title":"Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B14","first-page":"e15","article-title":"Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea","volume":"46","year":"2017","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.amjcard.2011.02.336","article-title":"Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization","volume":"107","year":"2011","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2008.12.013","article-title":"Endothelial dysfunction and cardiovascular risk factors","volume":"84","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B17","first-page":"Iii39","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijcard.2007.10.044","article-title":"Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase","volume":"131","year":"2009","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00002018-200124060-00003","article-title":"Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels","volume":"24","year":"2001","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJM199106273242602","article-title":"Variability of body weight and health outcomes in the Framingham population","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-010-0148-x","article-title":"Statin rebound or withdrawal syndrome: does it exist?","volume":"13","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehn346","article-title":"Discontinuation of statin therapy following an acute myocardial infarction: a population-based study","volume":"29","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4093\/dmj.2014.38.1.64","article-title":"Statin discontinuation after achieving a target low density lipoprotein cholesterol level in type 2 diabetic patients without cardiovascular disease: a randomized controlled study","volume":"38","year":"2014","journal-title":"Diabetes Metab J"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/01.wnl.0000269789.09277.47","article-title":"Statin treatment withdrawal in ischemic stroke: a controlled randomized study","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B25","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","article-title":"Withdrawal of statins increases event rates in patients with acute coronary syndromes","volume":"105","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B26","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/STROKEAHA.107.490292","article-title":"Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study","volume":"38","year":"2007","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ije\/dyg106","article-title":"Cholesterol, coronary heart disease, and stroke in the Asia Pacific region","volume":"32","author":"Asia Pacific Cohort Studies Collaboration","year":"2003","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20171221045504_ehx585-B28"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/48\/3560\/22964481\/ehx585.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T05:01:34Z","timestamp":1513832494000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/38\/48\/3560\/4554832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,21]]},"references-count":28,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2017,10,21]]},"published-print":{"date-parts":[[2017,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx585","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,21]]},"published":{"date-parts":[[2017,10,21]]}}}